Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




EULAR 2009: Statins Achieve Similar Secondary Prevention Benefits in Patients With and Without Rheum
Link ID 16708
Title EULAR 2009: Statins Achieve Similar Secondary Prevention Benefits in Patients With and Without Rheum
Url http://www.medscape.com/viewarticle/704547?src=rss
Description This finding adds to the growing body of evidence supporting the value of initiating statin therapy in rheumatoid arthritis patients, especially those with evidence of coronary heart disease. Medscape Medical News
Category Articles > Rheumatology
Keywords
Date Jun 19, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Obesity May Protect Against Joint Damage in Rheumatoid Arthritis
  Joint damage due to rheumatoid arthritis (RA) appears to be more severe among patients with a normal body mass index (BMI) than among their obese counterparts, a German research team reports. Reuters Health Information
Category:   Articles > Rheumatology


2. Systemic Lupus Erythematosus: From the Clinic to New Treatments
  A summary by Jonathan Kay, MD, of new treatment for the management of systemic lupus erythematosus, as illustrated by data presented at EULAR 2008.
Medscape Rheumatology
Category:   Articles > Rheumatology


3. Goal-Directed Therapy Pays Off in RAGoal-Directed Therapy Pays Off in RA
  Regular monitoring and treating to a DAS-28 score of less than 2.6 produces better RA outcomes than not monitoring DAS-28 or the HAQ-Disability Index score. Medscape Medical News
Category:   Articles > Rheumatology


4. Targeted Therapy for Systemic Sclerosis: How Close Are We?
  This new review explores a wide array of new therapeutic options for the treatment of systemic sclerosis, including biologic and immunosuppressive therapies, among others. Nature Reviews Rheumatology
Category:   Articles > Rheumatology


5. Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication a
  The publication status of all efficacy trials carried out in support of new drug approvals from 2001 and 2002 is reviewed. Why are a quarter of trials still unpublished? PLoS Medicine
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS